Rhabdomyosarcoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Rhabdomyosarcoma}} | {{Rhabdomyosarcoma}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
==Medical Therapy== | ==Medical Therapy== | ||
All patients with rhabdomyosarcoma require multimodality therapy with systemic [[chemotherapy]], in conjunction with either surgery, radiation therapy (RT), or both modalities to maximize local tumor control. | |||
==References== | ==References== | ||
Revision as of 18:19, 4 September 2015
|
Rhabdomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhabdomyosarcoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Rhabdomyosarcoma medical therapy |
|
Risk calculators and risk factors for Rhabdomyosarcoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
All patients with rhabdomyosarcoma require multimodality therapy with systemic chemotherapy, in conjunction with either surgery, radiation therapy (RT), or both modalities to maximize local tumor control.